The Care Inspectorate today welcomed the findings from the “Review of NHS Pharmaceutical Care of Patients in the Community in Scotland".
Paul Edie, Chair, said: "Changing demography, associated changes in morbidity and health inequalities are major challenges for Scotland. The review recognises that medicines are the commonest form of treatment in the NHS, and sets out how person- centred, sustainable pharmaceutical care should be developed in line with government policy of reshaping care.
"The review recognises the significant developments that have taken place in community based pharmaceutical care in Scotland, at the same time recognising the need to develop these using an integrated and multi-professional approach to secure most benefit for people.
"The report mentions the importance of person and carer involvement in this relationship, and the Care Inspectorate strongly supports this.
"We welcome the fact that the specific needs of residents in care homes and care at home services are recognised. We support the idea that consistent clinical input from a suitably trained pharmacist, working in partnership with any other professionals involved, including care staff, is fundamental to improving pharmaceutical care for people who use care services.
"The report calls for supply of medicines to care homes to be delivered through local not distant providers, and for national agreed standards of service, monitored by the NHS and which complements the clinical service. We recognise the view that practice in care at home service would benefit from more consistent approaches and national guidance.
"The Care Inspectorate welcomes the report and we look forward to working with the Scottish government and relevant interested parties to take forward the recommendations."